老虎證券

BUZZ-Cassava Sciences shares drop as Alzheimer's drug fails in late-stage study

Reuters
2024/11/25
BUZZ-Cassava Sciences shares drop as Alzheimer's drug fails in late-stage study

** Shares of drug developer Cassava Sciences SAVA.O down 85.42% premarket to $3.86, its experimental Alzheimer's disease drug, simufilam, did not meet the main or secondary goals in a late-stage study.

** As a result, Cassava will discontinue a second late-stage study, as well as its open-label study of the drug

** Cassava's shares were halted in premarket hours ahead of the announcement

** Up to the previous session's close, shares were up 17.6%​ YTD

(Repoting by Joao Manuel Mauricio)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10